Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2025 for a quick interview about the current and future state of pharma marketing.
From Awareness to Care Progression: Why the Funnel Isn’t Fixed at the First Click Biopharma
Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration For pharmaceutical marketers, campaign performance often
New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care Pharmaceutical brands are
Fierce Pharma highlights pharma’s shift toward direct-to-patient models A recent Fierce Pharma article examines how
From Awareness to Care Progression: Why the Funnel Isn’t Fixed at the First Click Biopharma teams know how to generate
Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration For pharmaceutical marketers, campaign performance often boils down to one metric:
New Performance Data Shows Why Pharma Is Reallocating Spend Toward Direct-to-Patient Care Pharmaceutical brands are increasingly shifting investment toward direct-to-patient
